Depakote
Product Images NDC 21695-359
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Depakote (NDC 21695-359). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Bfbc2cfb 8e96 4cf2 81c7 D63a1b7365c4 02)
This is a chart depicting the reduction in CPS (complex partial seizures) rate in patients using Depakote versus a placebo. The chart indicates a 100% reduction in CPS rate for those taking Depakote, and a 50% reduction for those taking the placebo. The chart also shows that there was improvement in the condition for a percentage of the patients studied, but it does not specify the exact percentage.*
Figure 2 (Bfbc2cfb 8e96 4cf2 81c7 D63a1b7365c4 03)
Figure 3 (Bfbc2cfb 8e96 4cf2 81c7 D63a1b7365c4 04)
Depakote 250mg (Bfbc2cfb 8e96 4cf2 81c7 D63a1b7365c4 05)
Depakote 500mg (Bfbc2cfb 8e96 4cf2 81c7 D63a1b7365c4 06)
This text provides information on a medication with the NDC code 2189616315. It appears to be a tablet of Dupahots 500mg with an extended release formula, with a package with 418 ER tablets, a lot code of NOG 2100816345, and an expiration date of 00005. It also includes information on the dosage, with "Lor #0000" and "ER Tablots | Aat Mase". The text contains some errors, so the accuracy of the information cannot be fully ensured.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.